FI861935A7 - Oxotiazolidinfoerening. - Google Patents

Oxotiazolidinfoerening. Download PDF

Info

Publication number
FI861935A7
FI861935A7 FI861935A FI861935A FI861935A7 FI 861935 A7 FI861935 A7 FI 861935A7 FI 861935 A FI861935 A FI 861935A FI 861935 A FI861935 A FI 861935A FI 861935 A7 FI861935 A7 FI 861935A7
Authority
FI
Finland
Prior art keywords
oxothiazole
info
oxothiazole info
Prior art date
Application number
FI861935A
Other languages
English (en)
Finnish (fi)
Other versions
FI861935A0 (fi
Inventor
Ikuo Ueda
Yousuke Katsura
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI861935A0 publication Critical patent/FI861935A0/fi
Publication of FI861935A7 publication Critical patent/FI861935A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Lubricants (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI861935A 1985-05-14 1986-05-09 Oxotiazolidinfoerening. FI861935A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858512163A GB8512163D0 (en) 1985-05-14 1985-05-14 Oxothiazolidine compound

Publications (2)

Publication Number Publication Date
FI861935A0 FI861935A0 (fi) 1986-05-09
FI861935A7 true FI861935A7 (fi) 1986-11-15

Family

ID=10579098

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861935A FI861935A7 (fi) 1985-05-14 1986-05-09 Oxotiazolidinfoerening.

Country Status (18)

Country Link
US (1) US4764514A (esLanguage)
EP (1) EP0203743B1 (esLanguage)
JP (1) JPS61267562A (esLanguage)
KR (1) KR860009009A (esLanguage)
AT (1) ATE60762T1 (esLanguage)
AU (1) AU593247B2 (esLanguage)
CA (1) CA1274515A (esLanguage)
DE (1) DE3677413D1 (esLanguage)
DK (1) DK222386A (esLanguage)
ES (2) ES8800185A1 (esLanguage)
FI (1) FI861935A7 (esLanguage)
GB (1) GB8512163D0 (esLanguage)
GR (1) GR861243B (esLanguage)
HU (1) HU195200B (esLanguage)
IL (1) IL78750A (esLanguage)
NO (1) NO861907L (esLanguage)
SU (2) SU1545941A3 (esLanguage)
ZA (1) ZA863285B (esLanguage)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0755937B2 (ja) * 1986-07-29 1995-06-14 日本曹達株式会社 オキサ(チア)ゾリジン誘導体その製造方法及び殺ダニ剤
CA1322199C (en) * 1987-07-15 1993-09-14 Masami Eigyo N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia
DE3875073T2 (de) * 1987-11-20 1993-03-11 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
US5066665A (en) * 1990-05-21 1991-11-19 Warner-Lambert Co. Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors
DE4404848A1 (de) * 1994-02-16 1995-08-17 Hoechst Ag Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate
CA2191874C (en) 1994-06-03 2008-05-20 Christopher Ian Brightwell Novel processes and intermediates for the preparation of piperazine derivatives
EP0783504B1 (en) * 1994-09-16 2000-03-15 Novo Nordisk A/S [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE AS ANTAGONISTS OF AMPA-RECEPTORS
US5596011A (en) * 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
US6359134B1 (en) 1997-05-30 2002-03-19 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
CN1290254A (zh) 1998-02-05 2001-04-04 武田药品工业株式会社 氨磺酰衍生物及其制备和用途
US6710061B2 (en) 2001-03-09 2004-03-23 Ortho-Mcneil Pharamceutical, Inc. Aminopyrrolidine sulfonamides as serine protease inhibitors
US6538017B2 (en) 2001-03-09 2003-03-25 Ortho-Mcneil Pharmaceutical, Inc. Aminopyrrolidine sulfonamides as serine protease inhibitors
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3309377A (en) * 1964-10-19 1967-03-14 Sterling Drug Inc 3-[(2-oxazolidinone-3-yl)-alkyl]-4-thiazolidinones and their preparation
IT1194793B (it) * 1981-05-12 1988-09-28 Corvi Camillo Spa Derivati tiazolidinici ad attivita' farmacologica,procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati
DE3315424A1 (de) * 1983-04-28 1984-12-20 Cassella Ag, 6000 Frankfurt Substituierte piperazin-1-yl-essigsaeure-amide, verfahren zu ihrer herstellung und ihre verwendung
FR2552762B1 (fr) * 1983-09-30 1986-07-25 Delalande Sa Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique
PT83152B (pt) * 1985-08-09 1989-03-30 Lilly Co Eli Processo para a preparacao de compostos di-t-butilfenoicos

Also Published As

Publication number Publication date
ES8802503A1 (es) 1988-07-16
SU1493107A3 (ru) 1989-07-07
DE3677413D1 (de) 1991-03-14
HUT41014A (en) 1987-03-30
KR860009009A (ko) 1986-12-19
HU195200B (en) 1988-04-28
FI861935A0 (fi) 1986-05-09
US4764514A (en) 1988-08-16
CA1274515A (en) 1990-09-25
ZA863285B (en) 1986-12-30
AU5727686A (en) 1986-11-20
ES8800185A1 (es) 1987-11-01
ATE60762T1 (de) 1991-02-15
ES557660A0 (es) 1988-07-16
EP0203743A1 (en) 1986-12-03
GR861243B (en) 1986-08-28
ES554901A0 (es) 1987-11-01
IL78750A0 (en) 1986-08-31
EP0203743B1 (en) 1991-02-06
JPS61267562A (ja) 1986-11-27
GB8512163D0 (en) 1985-06-19
IL78750A (en) 1990-12-23
NO861907L (no) 1986-11-17
AU593247B2 (en) 1990-02-08
JPH0455431B2 (esLanguage) 1992-09-03
DK222386D0 (da) 1986-05-13
DK222386A (da) 1986-11-15
SU1545941A3 (ru) 1990-02-23

Similar Documents

Publication Publication Date Title
DE3681208D1 (de) Fluormeter.
ATE77088T1 (de) 8-phenylxanthine.
FI863520A7 (fi) Datakommunikationsfoerfarande.
DE3677710D1 (de) Cefuroximaxetil-dragee.
DE3685611D1 (de) Polysiloxanelastomer.
ATE55980T1 (de) 2-hydroxy-3-phenoxypropylamine.
DE3668776D1 (de) Endotubus.
DE3668381D1 (de) Contactlinse.
ATE50243T1 (de) Fluorbenzylester.
DE3687867D1 (de) Mikrorechner.
DE3676026D1 (de) Terpolymerisate.
FI83377B (fi) Mikrovaogsugn.
DE3669772D1 (de) Russblaeser.
FI80864B (fi) Roerlig elevatortransportoer.
DE3688642D1 (de) Fdm-tdm-transmultiplexer.
DE3677472D1 (de) Blockierverhinderer.
DE3680606D1 (de) Loetapparat.
FI870593A0 (fi) Tipplyftare.
DE3686729D1 (de) Aminoalkylpyridinamide.
DE3683724D1 (de) Zahnstutz.
FI862375L (fi) Hjaertstimulerande tetrahydroimidazokinazolinoner.
DE3673520D1 (de) Perfluorpolyaether.
DE3670979D1 (de) Raederfalzapparat.
FI871606A0 (fi) Mottagarprocessor.
EP0217961A4 (en) Miticide.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO LTD